Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Current Deferred Revenue (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Current Deferred Revenue readings, the most recent being $9.5 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 19.47% to $9.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.5 million, a 19.47% decrease, with the full-year FY2025 number at $9.5 million, down 19.47% from a year prior.
  • Current Deferred Revenue hit $9.5 million in Q4 2025 for Tandem Diabetes Care, down from $9.8 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $44.0 million in Q4 2023 to a low of $1.1 million in Q1 2024.
  • Median Current Deferred Revenue over the past 5 years was $10.9 million (2022), compared with a mean of $15.3 million.
  • Biggest five-year swings in Current Deferred Revenue: plummeted 95.3% in 2024 and later skyrocketed 897.91% in 2025.
  • Tandem Diabetes Care's Current Deferred Revenue stood at $10.2 million in 2021, then skyrocketed by 85.0% to $18.8 million in 2022, then soared by 133.55% to $44.0 million in 2023, then tumbled by 73.11% to $11.8 million in 2024, then fell by 19.47% to $9.5 million in 2025.
  • The last three reported values for Current Deferred Revenue were $9.5 million (Q4 2025), $9.8 million (Q3 2025), and $10.5 million (Q2 2025) per Business Quant data.